NCT04220853

Brief Summary

Pathological-anatomical changes in the nasal cavity (nasal septum/perforation, mucosal hypertrophy) negatively affect nasal airflow, increase resistance - cause nasal obstruction and are often an indication for surgery. The aim of the study is to examine nasal airflow parameters after septoplasty and turbinoplasty .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 7, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

3 years

First QC Date

September 4, 2019

Last Update Submit

December 6, 2022

Conditions

Keywords

nasal obstructionseptoplastyturbinoplastynasal mucosanasal septum

Outcome Measures

Primary Outcomes (3)

  • Changes in resistance

    Changes in resistance (measured in Pa-s/ml - Pascal-second/millilitre) will be assessed with rhinomanometry 6 and 12 weeks after surgery.

    6 and 12 weeks after surgery

  • Changes in airflow

    Changes in airflow (measured in ml/s - millilitres/second) will be assessed with rhinomanometry 6 and 12 weeks after surgery.

    6 and 12 weeks after surgery

  • Changes in the cross-sectional area of the nasal passage

    Changes in the cross-sectional area of the nasal passage will be assessed with acoustic rhinometry 6 and 12 weeks after surgery.

    6 and 12 weeks after surgery

Study Arms (3)

Septoplasty

EXPERIMENTAL

The patients indicated for septoplasty will be included in this arm. The patients will undergo rhinomanometry and acoustic rhinometry after the surgery.

Diagnostic Test: Rhinomanometry in patients after septoplasty and/or turbinoplastyDiagnostic Test: Acoustic rhinometry in patients after septoplasty and/or turbinoplasty

Turbinoplasty

EXPERIMENTAL

The patients indicated for turbinoplasty will be included in this arm. The patients will undergo rhinomanometry and acoustic rhinometry after the surgery.

Diagnostic Test: Rhinomanometry in patients after septoplasty and/or turbinoplastyDiagnostic Test: Acoustic rhinometry in patients after septoplasty and/or turbinoplasty

Septoplasty and turbinoplasty

EXPERIMENTAL

The patients indicated for septoplasty and turbinoplasty will be included in this arm. The patients will undergo rhinomanometry and acoustic rhinometry after the surgery.

Diagnostic Test: Rhinomanometry in patients after septoplasty and/or turbinoplastyDiagnostic Test: Acoustic rhinometry in patients after septoplasty and/or turbinoplasty

Interventions

Rhinomanometry is an examination used to assess changes in resistance and airflow in patients after septoplasty and/or turbinoplasty.

SeptoplastySeptoplasty and turbinoplastyTurbinoplasty

Acoustic rhinometry is an examination used to assess changes in the cross-sectional area of the nasal passage in patients after septoplasty and/or turbinoplasty.

SeptoplastySeptoplasty and turbinoplastyTurbinoplasty

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with nasal obstruction (nasal septal deviation, hypertrophy of nasal mucosa)
  • to 70 Years
  • patient capable of general anesthesia
  • signing of the informed consent

You may not qualify if:

  • \- patient incapable of general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

Location

Related Publications (4)

  • Parthasarathi K, Christensen JM, Alvarado R, Barham HP, Sacks R, Harvey RJ. Airflow and symptom outcomes between allergic and non-allergic rhinitis patients from turbinoplasty. Rhinology. 2017 Dec 1;55(4):332-338. doi: 10.4193/Rhin16.210.

    PMID: 28888024BACKGROUND
  • Ottaviano G, Fokkens WJ. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice. Allergy. 2016 Feb;71(2):162-74. doi: 10.1111/all.12778.

    PMID: 26447365BACKGROUND
  • Borojeni AAT, Garcia GJM, Moghaddam MG, Frank-Ito DO, Kimbell JS, Laud PW, Koenig LJ, Rhee JS. Normative ranges of nasal airflow variables in healthy adults. Int J Comput Assist Radiol Surg. 2020 Jan;15(1):87-98. doi: 10.1007/s11548-019-02023-y. Epub 2019 Jul 2.

    PMID: 31267334BACKGROUND
  • Mlynski G, Grutzenmacher S, Plontke S, Mlynski B, Lang C. Correlation of nasal morphology and respiratory function. Rhinology. 2001 Dec;39(4):197-201.

    PMID: 11826688BACKGROUND

MeSH Terms

Conditions

Nasal Obstruction

Interventions

RhinomanometryRhinometry, Acoustic

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesAirway ObstructionRespiratory InsufficiencyRespiration DisordersOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisManometryInvestigative Techniques

Study Officials

  • Marek Plášek, MD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking will be used in the study.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: The patients will be divided into three parallel groups, depending on the indicated surgery - septoplasty, turbinoplasty, and septoplasty plus turbinoplasty.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2019

First Posted

January 7, 2020

Study Start

October 1, 2019

Primary Completion

September 30, 2022

Study Completion

October 31, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers.

Locations